about
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAsA coding-independent function of gene and pseudogene mRNAs regulates tumour biologyPseudogenes in Human CancerThe proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescenceThe novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanomaBcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatmentThe landscape of BRAF transcript and protein variants in human cancer.Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo.Pseudogenes: newly discovered players in human cancer.PTEN ceRNA networks in human cancer.The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide.Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.Alkaline Phosphatase-Positive Immortal Mouse Embryo Fibroblasts Are Cells in a Transitional Reprogramming State Induced to Face Environmental Stresses.Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.Deletion of PTENP1 pseudogene in human melanoma.Resting smooth muscle cells as a model for studying vascular cell activation.Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes.Methods for the Identification of PTEN-Targeting MicroRNAs.miRNAs regulate miRNAs: coordinated transcriptional and post-transcriptional regulation.Identification of BRAF 3'UTR Isoforms in Melanoma.Biological role of miR-204 and miR-211 in melanomaErratum to: Long non-coding RNAs in cancer: implications for personalized therapyLong non-coding RNAs in cancer: implications for personalized therapyMicroRNAs modulate the angiogenic properties of HUVECsAntitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanomaEarly modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenibDevelopment of a yeast-based system to identify new hBRAFV600E functional interactorsSystematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNAPTENP1 is a ceRNA for PTEN: it's CRISPR clear
P50
Q24629589-8F2A0B33-1223-4392-9DFE-18090B4D1738Q24632651-ADB6F301-4C9C-4605-A321-389E17006BD3Q26781044-02EF16AE-4E82-454A-B1B2-F742DFC83686Q28473050-C93BA2EF-66AF-4178-A8D5-99DD78E9BE9AQ28744417-FCCAD13B-31FA-4B7A-AAB1-B468E87CD59BQ31038879-F0567566-4432-42FB-8446-5E50C99B31DCQ33617734-460100D1-23B2-4CCD-89C3-7C8DB58B7917Q34109986-E4619795-A6E0-4DB5-AF08-005BE756CBB6Q34761998-AD6AA88A-A288-4C74-9885-44A707CAA265Q34993968-E9C58537-0967-47E9-A98C-1BFCBA9363CDQ37156452-D2D24E8A-F5A6-4A1D-9EF6-193289AB7A6AQ37370438-809537F0-003C-47D0-B411-BAC3DC5E1A99Q38044588-56EDE4D9-EC34-4749-9BF7-DFC9A220A7DDQ38341492-19641896-13C1-463A-8E27-1C6A9B54CF4AQ38363836-12A0DD82-A656-4758-B59C-DFC6A809B905Q38912800-D2B4E190-4A9D-476E-AE03-182C15812BB3Q40133831-6B7686AD-C95E-4260-8AC3-F67D3DE5B615Q41862341-22696D2A-D8EB-4648-BEBE-24256C125624Q42965863-2C418169-D649-469F-8D27-2541B822A2D2Q45855907-1943BADE-429A-429E-9125-6289BA1FD85CQ47103159-BBAC77D2-B1EC-47AE-8EEF-97D99CDF47A3Q50677169-BA1FE17B-FAFE-4239-8A4A-1D804B1D2182Q53588475-6103E151-43E5-412A-895C-431BB65230AFQ54290095-7DE14C0E-9812-4282-8BF5-1CD002FD0598Q58718139-B87029F8-5145-4CA3-9459-9DBEB53B2DCDQ62083227-945A5BAF-C8E0-460C-B9B0-D545B364F0BEQ62083228-CB5D67FB-83EA-4817-91D6-CD4164C901DFQ62083234-A2EECDBE-C95E-4E84-A614-68854B105EE4Q91142544-68E1EE1C-C969-4ECC-AF98-B8351E8FC651Q91241914-CFAD38B2-6751-48C1-AEF8-98796D458131Q91598237-A8357FEE-C7E0-4273-AAE5-535F45AC3109Q92724796-F8B6DD78-7D52-470D-8375-30D2ABDFE93CQ96227979-B04FE55E-69D4-45E0-A80F-3D68D26AFDE3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Laura Poliseno
@ast
Laura Poliseno
@en
Laura Poliseno
@es
Laura Poliseno
@nl
Laura Poliseno
@sl
type
label
Laura Poliseno
@ast
Laura Poliseno
@en
Laura Poliseno
@es
Laura Poliseno
@nl
Laura Poliseno
@sl
prefLabel
Laura Poliseno
@ast
Laura Poliseno
@en
Laura Poliseno
@es
Laura Poliseno
@nl
Laura Poliseno
@sl
P108
P214
P244
P1053
B-5711-2012
P106
P1153
7801522153
P21
P214
P244
nb2014015117
P31
P3829
P496
0000-0001-6557-955X
P734
P735
P7859
lccn-nb2014015117